Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.145 USD | -2.50% | -3.81% | +10.57% |
Mar. 04 | North American Morning Briefing : Stock Futures -2- | DJ |
Feb. 28 | Lyell Immunopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.57% | 561M | |
-1.83% | 103B | |
+0.46% | 95.71B | |
+1.69% | 22.02B | |
-17.30% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.84% | 15.52B | |
+3.92% | 13.86B | |
+35.57% | 12.04B |
- Stock Market
- Equities
- LYEL Stock
- News Lyell Immunopharma, Inc.
- Lyell Immunopharma : Morgan Stanley Starts Lyell Immunopharma at Overweight With $25 Price Target